老年重症COVID-19患者气管切开时机与结局的欧洲前瞻性观察研究
该研究在16个欧洲国家152个中心前瞻性纳入1740例≥70岁、需有创机械通气的COVID-19重症患者,其中461例(26.5%)行气管切开,135例(29.3%)为早期气管切开(插管后≤10天)。多变量分析显示早期与晚期气管切开在3个月死亡率上无差异(HR=0.96;95%CI 0.70-1.33),各国气管切开率差异较大(8.3%至52.9%)。
要点
- 老年COVID-19重症患者早期气管切开(≤10天)与晚期相比未改善3个月生存。
- 欧洲各国气管切开率差异大,从8.3%至52.9%。
- 气管切开时机决策需个体化,不应仅基于早期切开可能获益的假设。
核心结论
- 在≥70岁重症COVID-19患者中,未发现早期气管切开(≤10天)与3个月死亡率存在关联。
研究设计与样本
- 前瞻性队列研究,2020年2月至12月在16个欧洲国家152个中心开展,纳入1740例≥70岁确诊COVID-19、需有创机械通气的ICU患者。
主要发现
- 461例(26.5%)行气管切开,其中135例(29.3%)为早期气管切开。
- 各国气管切开率从8.3%至52.9%不等。
- 主要分析中早期与晚期气管切开3个月死亡率无差异(HR=0.96;95%CI 0.70-1.33)。
- 次要landmark分析同样无差异(HR=0.78;95%CI 0.57-1.06)。
临床怎么用
- 对于老年重症COVID-19患者,气管切开时机选择应基于个体化评估,不应仅以缩短机械通气或改善生存为目的而倾向早期切开。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Tracheostomy is performed in patients expected to require prolonged mechanical ventilation, but to date optimal timing of tracheostomy has not been established. The evidence concerning tracheostomy in COVID-19 patients is particularly scarce. We aimed to describe the relationship between early tracheostomy (≤10 days since intubation) and outcomes for patients with COVID-19. METHODS: This was a prospective cohort study performed in 152 centres across 16 European countries from February to December 2020. We included patients aged ≥70 yr with confirmed COVID-19 infection admitted to an intensive care unit, requiring invasive mechanical ventilation. Multivariable analyses were performed to evaluate the association between early tracheostomy and clinical outcomes including 3-month mortality, intensive care length of stay, and duration of mechanical ventilation. RESULTS: The final analysis included 1740 patients with a mean age of 74 yr. Tracheostomy was performed in 461 (26.5%) patients. The tracheostomy rate varied across countries, from 8.3% to 52.9%. Early tracheostomy was performed in 135 (29.3%) patients. There was no difference in 3-month mortality between early and late tracheostomy in either our primary analysis (hazard ratio [HR]=0.96; 95% confidence interval [CI], 0.70-1.33) or a secondary landmark analysis (HR=0.78; 95% CI, 0.57-1.06). CONCLUSIONS: There is a wide variation across Europe in the timing of tracheostomy for critically ill patients with COVID-19. However, we found no evidence that early tracheostomy is associated with any effect on survival amongst older critically ill patients with COVID-19. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov NCT04321265.
引用
- Polok K, Fronczek J, van Heerden PV, et al. Association between tracheostomy timing and outcomes for older critically ill COVID-19 patients: prospective observational study in European intensive care units. Br J Anaesth. 2021. PMID: 34955167. doi:10.1016/j.bja.2021.11.027
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。